AXL-IN-13
AXL-IN-13 is a potent and orally active AXL inhibitor with an IC50 of 1.6 nM and a Kd of 0.26 nM. It exhibits anticancer activity, reverses TGF-β1-induced epithelial-mesenchymal transition (EMT), and inhibits cancer cell migration and invasion.
Product Specifications
CAS Number
2376928-82-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
632.72
Molecular Formula
C34H41FN6O5
Notes
Research use only, not for human use.
Receptor
FLT | PDGFR | TGF-beta/Smad | TAM Receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A10866-FITC 100 µg/Vial
Anti-SHROOM4 Antibody Picoband®, FITC Conjugate
Sign In for Pricing
View Details K2542308 1.0 µg DNA
TSPAN13 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
MBS2114963-01 0.1 mL
FITC-Linked Polyclonal Antibody to Sphingosine Kinase 2 (SPHK2)
Sign In for Pricing
View Details